Substituted anthranilamides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis as well as their intermediate products for the production of anthranilamides are described.
Anthranilamides and their use as pharmaceutical agents
申请人:Krueger Martin
公开号:US20050261343A1
公开(公告)日:2005-11-24
Substituted anthranilamides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis as well as their intermediate products for the production of anthranilamides are described.